Jennifer Brown, MD, PhD, Director, Chronic Lymphocytic Leukemia Center, Dana-Farber Cancer Institute, Assistant Professor of Medicine, Harvard Medical School, discusses the treatment of chronic lymphocytic leukemia with ibrutinib, idelalisib, etc.
Video, Dr. Jennifer Brown.... ibrutinib, idela... - CLL Support
Video, Dr. Jennifer Brown.... ibrutinib, idelalisib, and other agents.
Written by
Cllcanada
Top Poster CURE Hero
To view profiles and participate in discussions please or .
Read more about...
1 Reply
•
Not what you're looking for?
You may also like...
Zanubrutinib vs. Ibrutinib Patient Power Video by Dr. Jennifer Brown MD PHD
In this Patient Power video - Dr. Brown is very clear about the advantages of Zanubrutinib over...
Vaccines, Ibrutinib toxicity,Dr. Rai on a cure, Dr Ghia on TP563 testing and ERIC
I warned that our website's pages would be busy through the end of the year.
I tried to synthesize...
Dr Sharman's thoughts on the race for FDA Approval for Obinituzumab, Ibrutinib and Idelalisib
Following Gilead's announcement regarding Idelalisib:...
Sequential And Combination Treatments With Novel Agents (Oct. 2019)
Superb overview/comparisons from Germany, published October 4, 2019.
"Chemoimmunotherapy has been...
Acalabrutinib Plus Obinutuzumab Prolongs Progression Free Survival Compared to Other Targeted Agents in Chronic Lymphocytic Leukaemia (CLL)
First-line acalabrutinib plus obinutuzumab prolongs progression-free survival (PFS) compared to...
Related Posts
Questions about Richter Syndrome
Trabectedin Targets Leukemic Cells and Restores Immune Cell Function in Models of Chronic Lymphocytic Leukemia- End of suspense! Here is Dr. Koffman's ASCO 2020 "Top Pick" #1!
Travel insurance covering chronic lymphocytic leukemia - ASH 2013: Dr. John Pagel Speculates on the Future of CLL Therapies including the late breaking data on Idelalisib
